All NBIX Content

Neurocrine Biosciences, Inc (NBIX) Sec Form 8K

Neurocrine Biosciences, Inc (NASDAQ: NBIX) Sec Form 8K

April 7, 20261 min read

Neurocrine Biosciences, Inc (NBIX) Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio

Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 M&A Release

April 6, 20261 min read

Neurocrine Biosciences, Inc (NBIX) Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings

Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 Other Release

March 26, 20261 min read

Neurocrine Biosciences, Inc (NBIX) Neurocrine Biosciences Appoints Andrew Ratz, Ph.D., as Chief Technical Operations Officer

Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 Management Update

March 17, 20261 min read

Neurocrine Biosciences, Inc (NBIX) Forum

Neurocrine Biosciences, Inc (NASDAQ: NBIX) Forum

March 10, 20261 min read

Neurocrine Biosciences, Inc (NBIX) Q4 2025 Earnings Call Transcript

Neurocrine Biosciences, Inc (NASDAQ: NBIX) Q4 2025 Earnings Call dated Feb. 11, 2026 Corporate Participants: Todd Tushla — Vice President...

March 10, 202648 min read

Neurocrine Biosciences, Inc (NBIX) Leerink Global Healthcare Conference.

Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 Corporate Conference

February 24, 20261 min read

Neurocrine Biosciences, Inc (NBIX) TD Cowen 46th Annual Health Care Conference

Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 Corporate Conference

February 24, 20261 min read

Neurocrine Biosciences, Inc (NBIX) Sec Form 10K

Neurocrine Biosciences, Inc (NASDAQ: NBIX) Sec Form 10K

February 12, 20261 min read

Neurocrine Biosciences, Inc (NBIX) Sec Form 8K

Neurocrine Biosciences, Inc (NASDAQ: NBIX) Sec Form 8K

February 12, 20261 min read